Santafe News Online

Microfluidics Market: Opportunities and Challenges

 Breaking News
  • No posts were found

Microfluidics Market: Opportunities and Challenges

October 19
18:18 2019
Microfluidics Market: Opportunities and Challenges

Some of the prominent players in the Microfluidics Market include Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm Microfluidics (US), and QIAGEN (Netherlands). Other key players include Dolomite Microfluidics (UK), GYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK)
Technologically advanced systems such as implantable drug delivery systems can provide significant growth opportunities for market players, as the microfluidics technology allows the fabrication of portable and wearable products that could ensure accurate and regular drug delivery.

The Microfluidics Market is valued at 8.28 billion in 2017 and is expected to grow at a CAGR of 22.6% during the forecast period, to reach to USD 27.91 billion by 2023 as per a report by MarketsandMarkets. 

Why expanding applications of drug delivery technologies presents an opportunity?

Technologically advanced systems such as implantable drug delivery systems can provide significant growth opportunities for market players, as the microfluidics technology allows the fabrication of portable and wearable products that could ensure accurate and regular drug delivery. The most widely used microfluidics-based drug delivery devices are insulin pumps, and currently, several related approaches for micropumps are under development. These devices are expected to be available on a larger scale within the next two to three years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1305

The major benefits of microfluidics technology, such as the controlled release of drugs and biocompatibility, are expected to provide significant opportunities for technology adoption. Apart from portable, wearable, and implantable devices, researchers are also focusing on developing intelligent pills and subcutaneous patches for controlled release. By using microtechnologies for making the diffusion barrier, the release can be controlled in a better way. To capture the high growth in this market, pharmaceutical and medical device companies are investing heavily in developing new drug delivery devices using microfluidics technologies.

How standardization/commercialization of microfluidic devices is a key challenge?

Customer acceptance and market adoption are the two major factors that affect the commercialization of any product or technology in the market. There are many academic publications of proof-of-concept for microfluidic technology-embedded medical devices and equipment, but the incorporation of this technology in end-use products has been limited over the last decade owing to the lack of standardized microfluidic devices that can be used by multiple end users.

Despite the fact that microfluidics is a promising laboratory tool and is used in some applications, the technology is still not widely adopted in major applications in the life sciences and medical device industries. In addition, investors and venture capitalists are more interested in investing their funds in projects or products that give them faster returns on investment. As a result, researchers are forced to redirect their focus from innovative technologies such as microfluidics to other marketable products.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1305

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. 

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. 

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/microfluidics-market-1305.html